Dizal (Jiangsu) Pharmaceutical Co., Ltd.

XSSC:688192 Stock Report

Market Cap: CN¥17.5b

Dizal (Jiangsu) Pharmaceutical Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Zhang Xiaolin

Chief executive officer

CN¥9.5m

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership1.8%
Management average tenure1.3yrs
Board average tenure4.3yrs

Recent management updates

Recent updates

CEO

Zhang Xiaolin (60 yo)

no data

Tenure

CN¥9,534,800

Compensation

Dr. Zhang Xiaolin Ph.D. is General Manager and Chairman of Dizal (Jiangsu) Pharmaceutical Co., Ltd. and served as its Chief Scientist. Dr. Xiaolin joined the Dizal (Jiangsu) Pharmaceutical Co., Ltd.in 201...

Leadership Team

NamePositionTenureCompensationOwnership
Zhang Xiaolin
GM & Chairmanno dataCN¥9.53m1.76%
CN¥ 308.2m
Lyu Hongbin
CFO & Board Secretary4.9yrsCN¥4.07mno data
Zhiwei Zhang
Deputy GM1.3yrsCN¥1.81m0.024%
CN¥ 4.2m
Qingbei Zeng
Deputy GMno dataCN¥2.03m0.072%
CN¥ 12.6m
Zhenfan Yang
Deputy GM & Chief Medical Officerno dataCN¥3.59m1.09%
CN¥ 191.3m
Qingyi Wu
Deputy GM & Chief Commercial Officerno dataCN¥5.23m0.0028%
CN¥ 497.7k
Honchung Tsui
Deputy GM1.3yrsCN¥2.31m0.072%
CN¥ 12.6m
Shih-Ying Chang
Deputy GMno dataCN¥2.76m0.0096%
CN¥ 1.7m
Suqin Chen
Deputy GM & Senior VP of Clinical Operationsno dataCN¥2.98m0.11%
CN¥ 19.4m
Weijun Qiao
VP & Head of Registration Affairs1.3yrsCN¥1.98m0.048%
CN¥ 8.4m
Kan Chen
Vice President of Clinical Pharmacologyno dataCN¥1.72m0.0072%
CN¥ 1.3m
Xiaojing Kang
Employee Supervisor & Head of Accounting Agencyno datano data0.0041%
CN¥ 716.7k

1.3yrs

Average Tenure

56yo

Average Age

Experienced Management: 688192's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Zhang Xiaolin
GM & Chairmanno dataCN¥9.53m1.76%
CN¥ 308.2m
Xiaojing Kang
Employee Supervisor & Head of Accounting Agency2.8yrsno data0.0041%
CN¥ 716.7k
Guanshan Zhu
Independent Director4.3yrsCN¥100.00kno data
Simon Dazhong Lu
Director7.9yrsno datano data
Rodolphe Peter Andre Grepinet
Director7.9yrsno datano data
Jiang Bin
Independent Director4.3yrsCN¥100.00kno data
Wang Xuegong
Independent Director4.3yrsCN¥100.00kno data
Zhang Xin
Independent Director4.3yrsCN¥100.00kno data
Dong Weiwen
Chairman of the Supervisory Boardno datano datano data
Yuan Sun
Supervisorno datano datano data

4.3yrs

Average Tenure

52yo

Average Age

Experienced Board: 688192's board of directors are considered experienced (4.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 17:16
End of Day Share Price 2024/12/25 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Dizal (Jiangsu) Pharmaceutical Co., Ltd. is covered by 8 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Pei ChengChina Galaxy Securities Co., Ltd.
Ziyu HeChina International Capital Corporation Limited
Jin ZhangChina International Capital Corporation Limited